12 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25695864	35	Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold.	Slovak Academy of Sciences
25375908	9	Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.	Universit£
24071447	39	Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.	Gifu Pharmaceutical University
21561086	21	Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.	Gifu Pharmaceutical University
22263837	262	Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17ß-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.	University of Pennsylvania
18087047	3	Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.	Universitat Aut£Noma De Barcelona
22104435	54	Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-ß-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.	University of Toyama
22236472	51	Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.	Gifu Pharmaceutical University
20304656	31	Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10.	Gifu Pharmaceutical University
28976752	51	Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells.	Gifu Pharmaceutical University